Literature DB >> 26377810

Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap?

Elaine Douglas1, Jo Waller1, Stephen W Duffy2, Jane Wardle3.   

Abstract

OBJECTIVE: Health policy in the UK is committed to tackling inequalities in cancer screening participation. We examined whether socioeconomic inequalities in breast and cervical cancer screening participation in England have reduced over five years.
METHODS: Cross-sectional analyses compared cervical and breast screening coverage between 2007/8 and 2012/13 in Primary Care Trusts (PCTs) in England in relation to area-level income deprivation.
RESULTS: At the start and the end of this five year period, there were socioeconomic inequalities in screening coverage for breast and cervical screening. Inequalities were highest for breast screening. Over time, the coverage gap between the highest and lowest quintiles of income deprivation significantly reduced for breast screening (from 12.3 to 8.3 percentage points), but not for cervical screening (5.3 to 4.9 percentage points).
CONCLUSIONS: Efforts to reduce screening inequalities appear to have resulted in a significant improvement in equitable delivery of breast screening, although not of cervical screening. More work is needed to understand the differences, and see whether broader lessons can be learned from the reduction of inequalities in breast screening participation.
© The Author(s) 2015.

Entities:  

Keywords:  cancer screening; coverage; socioeconomic inequalities

Mesh:

Year:  2015        PMID: 26377810      PMCID: PMC4855247          DOI: 10.1177/0969141315600192

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


Introduction

The National Health Service (NHS) Breast and Cervical Screening Programmes were introduced in the UK in 1988. In England, breast screening is offered every three years to women aged 50–70, with an age-extension from 47–73 years currently being rolled out.[1] In the face of recent debate about the value of the breast screening, an independent review was carried out in 2012, which concluded that, on balance, screening is beneficial.[2] Cervical screening is offered to women aged 25–64, every three years for women aged 25–49 and every five years for those aged 50–64.[3] Both programmes use a ‘call-recall’ system in which women receive invitations, re-invitations, and reminders, as recommended by the World Health Organization (http://www.who.int/cancer/detection/variouscancer/en/). Coverage (defined as breast screening within the past three years, and cervical screening within the past five years) is high for both programmes: currently 77% for breast screening[4] and 78% for cervical screening,[3] although cervical screening coverage has been declining, particularly in younger women,[3] and has not reached its 80% target since 2005. There is also long-standing concern that coverage across both programmes is lower among women from lower socioeconomic status (SES) backgrounds. Using area-level measures of SES, breast and cervical screening coverage has been found to be lower in more deprived areas.[5-9] Using individual-level measures, women who live in rented accommodation or in households without cars have been shown to be significantly less likely to attend breast screening.[10] Educational level has also been associated with lower cervical screening coverage in a number of national surveys.[10-13] Inequalities in coverage of breast and cervical screening are likely to be contributing to inequalities in cancer outcomes.[14,15] Successive UK governments have made policy commitments to tackling inequalities in cancer screening participation.[1,16] Building on this commitment, there have been many local activities designed to promote screening coverage in deprived areas. These have adopted a variety of strategies, including GP endorsement, addressing programme-specific barriers, and developing socially and culturally appropriate invitation approaches.[17,18] Cumulatively, these may have contributed to a reduction in socioeconomic inequalities in screening coverage over time. Until 2013, Primary Care Trusts (PCTs) were responsible for screening coverage within their areas. National, quality-assured PCT-level coverage data are available for download from the NHS Health and Social Care Centre and are not subject to self-report bias inherent in individual-level data. The present study therefore examined associations between area-level deprivation and breast and cervical screening coverage in England from 2007 to 2012.

Methods

PCT[1] data on breast and cervical screening coverage for the period 2007–2012 were downloaded from the Health and Social Care Information Centre.[4,19] We included data from all 151 PCTs in England, 31 of which were in London. Breast screening coverage data were for women aged 53–70. Breast screening coverage is defined as the percentage of eligible women who have had a test with a recorded result in the last three years.[4] Cervical screening data were available for women aged 25–64, but we also subdivided the sample into those aged 25–49 (using 3.5 year coverage) and 50–64 (using five year coverage), for age-matched comparison with breast screening. Cervical screening coverage is defined as the percentage of eligible women who have had a test with a recorded result in the last 3.5 years for those aged 25–49 and in the last five years for those aged 50–64.[4] We used the income domain score from the Index of Multiple Deprivation (IMD) 2010 as the marker of deprivation. This is an area-level measure based on the number of households on low income, benefits or other welfare support. The score is the proportion of people classed as income deprived, and is calculated using a population-weighted average of Lower Super Output Area income deprivation score, aggregated to PCT level. IMD scores at PCT level were downloaded from the National Gynaecological Hub.[20] IMD scores were categorized into quintiles for the primary analyses.

Statistical analysis

Data were analysed using Stata version 10.1.[21] Descriptive statistics were generated for PCT-level coverage of both screening programmes. To describe the relationship between screening coverage and income deprivation, we fitted a Poisson regression model by quintiles of IMD. We examined changes over time by testing for an interaction between time and income deprivation in their combined effect on coverage in the Poisson regression model. This is equivalent to estimating and testing the effect of the product of year and IMD on coverage.

Results

Screening Coverage

Annual coverage figures for the two programmes from 2007 to 2012 are shown in Table 1. Overall, breast screening coverage was fairly stable at 74–75%, although the range shows that there was an improvement in the worst-performing PCTs, with the minimum coverage increasing from 43.9% in 2007/8 to 58.3% in 2012/13. Overall cervical screening coverage was also stable at around 78%, with little change in the range across PCTs.
Table 1.

Descriptive statistics for breast and cervical screening coverage within PCTs, England (2007–2012).

Breast screening coverage (%)
Cervical screening coverage (%)
YearMin-MaxMeanSDMin-MaxMeanSD
2007–0843.9–84.674.68.166.7–85.778.13.7
2008–0950.9–84.875.17.665.8–85.878.53.8
2009–1056.9–85.075.66.266.4–85.478.53.6
2010–1159.8–85.175.95.367.2–84.378.33.4
2011–1259.5–84.775.65.165.9–83.878.33.4
2012–1358.3–83.374.85.365.5–83.578.03.4
Descriptive statistics for breast and cervical screening coverage within PCTs, England (2007–2012).

Deprivation and Screening Coverage

Figure 1 shows breast screening coverage by PCT-level quintile of income deprivation across the time period of the study. In 2007, the difference in coverage between the least deprived (Q1) and most deprived (Q5) quintile was 12.3 percentage points. Coverage in the less deprived quintiles changed little, but coverage in Q5 increased from 66.3% to 69.8%, suggesting that inequalities improved over time. Table 2 shows the relative rates of coverage from the Poisson regression. Poisson regression models for each year showed that Q3, Q4 and Q5 had significantly lower coverage than Q1 (see Table 2). However, the relative coverage for Q5 was 0.85 (95% CI 0.84–0.86) in 2007/8 and increased to 0.89 (95% CI 0.88–0.90) in 2012/13. There was significant heterogeneity in the association of coverage with income deprivation by year (p < 0.0001), with the strength of the negative association declining significantly with successive years.
Figure 1.

Breast screening coverage by quintile of area-level deprivation within PCTs, England, age 53–70 (2007–12).

Table 2.

Results of Poisson regression of breast screening coverage on quintiles of deprivation by year, England (2007–12).

YearDeprivation quintileRR*95% CIs
Average % coveragep
LowerUpper
2007–08Q1 (reference)1.0079
Q20.990.981.0077<.0001
Q30.940.930.9573<.0001
Q40.940.930.9574<.0001
Q5 (most deprived)0.850.840.8666<.0001
2008–09Q1 (reference)1.0079
Q2−.990.981.0078<.0001
Q30.930.920.9473<.0001
Q40.950.940.9675<.0001
Q5 (most deprived)0.860.850.8768<.0001
2009–10Q1 (reference)1.0079
Q21.000.991.0178.2
Q30.950.940.9675<.0001
Q40.950.940.9675<.0001
Q5 (most deprived)0.880.870.8970<.0001
2010–11Q1 (reference)1.0079
Q20.990.981.0078<.0001
Q30.960.950.9776<.0001
Q40.950.940.9675<.0001
Q5 (most deprived)0.890.880.9070<.0001
2011–12Q1 (reference)1.0079
Q20.990.981.0078.01
Q30.950.940.9675<.0001
Q40.950.940.9675<.0001
Q5 (most deprived)0.890.880.9070<.0001
2012–13Q1 (reference)1.0078
Q21.000.991.0178.6
Q30.960.950.9775<.0001
Q40.950.940.9674<.0001
Q5 (most deprived)0.890.880.9070<.0001

Relative rate of coverage.

Breast screening coverage by quintile of area-level deprivation within PCTs, England, age 53–70 (2007–12). Results of Poisson regression of breast screening coverage on quintiles of deprivation by year, England (2007–12). Relative rate of coverage. Figure 2 shows cervical screening coverage for women aged 25–64 by quintile of income deprivation. In 2007, the difference in coverage between Q1 and Q5 was 5.3 percentage points, considerably smaller than the breast screening coverage gap. Unlike the pattern for breast screening, coverage was fairly stable across time in all quintiles, with little evidence of a reduction in the socioeconomic gradient, although there was a relatively high coverage in the least deprived quintile in 2009–10, yielding a stronger gradient for that year. As with breast screening, Poisson regression analyses showed that Q3, Q4 and Q5 (and in most years Q2) had significantly lower cervical screening coverage than Q1 (Table 3). The coverage gradient ran from 80% (least deprived) to 75% (most deprived) in both 2007–08 and 2012–13. There was significant heterogeneity in the relationship between coverage and income deprivation across years (p < 0.0001). This was not due to a decline in the gradient over time, but rather a peak in the gradient in year 2009–10.
Figure 2.

Cervical screening coverage by quintile of deprivation within PCTs, England, age 25–64 (2007–12).

Table 3.

Results of Poisson regression of cervical screening coverage on quintiles of deprivation by year, England (2007–12).

YearDeprivation quintileRR*95% CIs
Average % coveragep
LowerUpper
2007–08Q1 (reference)1.0080
Q21.000.991.0180.4
Q30.960.950.9778<.0001
Q40.950.940.9677<.0001
Q5 (most deprived)0.930.920.9475<.0001
2008–09Q1 (reference)1.0081
Q20.990.981.0080.008
Q30.960.950.9778<.0001
Q40.950.940.9678<.0001
Q5 (most deprived)0.930.920.9476<.0001
2009–10Q1 (reference)1.0084
Q20.930.920.9480<.0001
Q30.890.880.9078<.0001
Q40.880.870.8977<.0001
Q5 (most deprived)0.860.850.8776<.0001
2010–11Q1 (reference)1.0081
Q20.990.981.0080<.0001
Q30.960.950.9778<.0001
Q40.950.940.9677<.0001
Q5 (most deprived)0.930.920.9475<.0001
2011–12Q1 (reference)1.0081
Q20.990.981.0080<.0001
Q30.970.960.9878<.0001
Q40.950.940.9677<.0001
Q5 (most deprived)0.930.920.9476<.0001
2012–13Q1 (reference)1.0080
Q20.990.981.0080<.0001
Q30.970.960.9878<.0001
Q40.950.940.9677<.0001
Q5 (most deprived)0.940.930.9575<.0001

Relative rate of coverage.

Cervical screening coverage by quintile of deprivation within PCTs, England, age 25–64 (2007–12). Results of Poisson regression of cervical screening coverage on quintiles of deprivation by year, England (2007–12). Relative rate of coverage. We repeated the cervical screening analyses restricted to women aged 50–64 (five year coverage data), to be age-comparable with the breast screening programme. The pattern of findings was very similar to the full age distribution. Figure 3 shows that the pattern of coverage across quintiles is much more similar to the pattern for cervical screening across all ages than the pattern of breast screening. This suggests that programmatic differences underlie the different patterns of association, rather than the age of the women invited.
Figure 3.

Cervical screening coverage by quintile of deprivation within PCTs, England, in women aged 50–64 (2007–12).

Cervical screening coverage by quintile of deprivation within PCTs, England, in women aged 50–64 (2007–12).

Discussion

Associations between income deprivation and screening coverage are well documented,[7,12,18] but few studies have examined whether inequalities are changing. We found, as expected, that PCTs with higher levels of income deprivation had lower coverage for both breast and cervical screening. However, for breast screening, the difference in coverage between the most and least deprived PCTs narrowed significantly over the five years from 2007/8 to 2012/13. This was not the case for cervical screening, even when the analyses were restricted to women of an age comparable with those in the breast screening programme. This suggests that while strategies to increase breast screening coverage in poorer areas of England may have been successful, the low uptake of cervical screening in poorer areas has been more resistant to change, though the coverage gap is still greater for breast than cervical screening. In 2012/13 the difference in coverage between the highest and lowest quintiles of income deprivation was 8.3 percentage points for breast screening and 4.9 percentage points for cervical, so there is still scope for improvement. Differences in screening coverage across the programmes may be due to the particular characteristics of each screening programme.[22] For example, women invited to cervical screening are asked to arrange an appointment for screening at their own General Practice, whereas women invited to breast screening are provided with a scheduled appointment at a breast screening unit, generally in a local hospital or mobile unit. However, as yet it is unclear whether these factors might have a differential impact on women from different socioeconomic backgrounds and therefore what their contribution to the SES gradients in coverage might be. There has been a suggestion that lower screening uptake – regardless of the characteristics of the unscreened group – should be respected as the result of an informed choice.[23] The evidence suggests otherwise. At least in the case of colorectal screening, the unscreened group is much less likely to read the information provided with the screening invitation.[24] This suggests that they are more likely to be unengaged than making an informed choice, particularly as their health literacy tends to be lower.[25] In addition, even in countries such as the UK, where medical care is delivered without cost to the individual, many barriers to screening across programmes - social, fear of the test, embarrassment - are more prevalent in more deprived groups.[26] Until we ensure that information and access are socially equitable, it is not appropriate to interpret uptake differences as a consequence of an informed choice. One unexpected finding was the peak in cervical screening coverage in 2009–10. This may have been related to death from cervical cancer of the television celebrity, Jade Goody,[27] though we are not aware of previous work which suggests that the impact was strongest among less deprived groups.

Strengths and Limitations

This study benefited from complete data on uptake as a result of using routinely collected data, so there were none of the problems associated with differential response rates in more deprived population subgroups. Methods of data collection over time were also the same, making it possible to interpret differences. But there were also limitations. Area-based measures of deprivation do not reflect the granularity of variation between individuals, and may therefore show a different relationship with behaviour.[28] However, this is the only option when using routinely collected data without individual permissions to access screening records. In this study they were based on scores at Lower Super Output Areas, which are relatively small, homogenized geographic units, and then weighted to PCT level, so they should be fairly accurate. In addition, we only used the income domain because the full IMD includes the health domain and may incur a ‘mathematical coupling’.[29]

Conclusion

A reduction in the breast screening coverage gap across English PCTs suggests that efforts to reduce screening inequalities may have had an effect. However, for cervical screening, there has been no discernible improvement in inequalities, although the magnitude of the inequality effect was consistently lower for cervical than breast screening. More work is needed to understand the differences, and to see what lessons can be learned from the reduction of inequalities in breast screening participation to apply to other programmes, such as colorectal screening, which have very high inequalities.
  18 in total

1.  Barriers to cervical cancer screening attendance in England: a population-based survey.

Authors:  Jo Waller; Marta Bartoszek; Laura Marlow; Jane Wardle
Journal:  J Med Screen       Date:  2009       Impact factor: 2.136

Review 2.  Interventions targeted at women to encourage the uptake of cervical screening.

Authors:  Thomas Everett; Andrew Bryant; Michelle F Griffin; Pierre Pl Martin-Hirsch; Carol A Forbes; Ruth G Jepson
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

3.  Screening for prevention and early diagnosis of cancer.

Authors:  Jane Wardle; Kathryn Robb; Sally Vernon; Jo Waller
Journal:  Am Psychol       Date:  2015 Feb-Mar

4.  Uptake in cancer screening programmes: a priority in cancer control.

Authors:  D P Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

5.  Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England.

Authors:  C von Wagner; A Good; D Wright; B Rachet; A Obichere; S Bloom; J Wardle
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

Review 6.  Methods to increase participation in organised screening programs: a systematic review.

Authors:  Laura Camilloni; Eliana Ferroni; Beatriz Jimenez Cendales; Annamaria Pezzarossi; Giacomo Furnari; Piero Borgia; Gabriella Guasticchi; Paolo Giorgi Rossi
Journal:  BMC Public Health       Date:  2013-05-13       Impact factor: 3.295

7.  Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.

Authors:  Lorraine Shack; Catrina Jordan; Catherine S Thomson; Vivian Mak; Henrik Møller
Journal:  BMC Cancer       Date:  2008-09-26       Impact factor: 4.430

8.  Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors.

Authors:  Laura G Currin; Ruth H Jack; Karen M Linklater; Vivian Mak; Henrik Møller; Elizabeth A Davies
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

9.  Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the 'Jade Goody effect' in the UK.

Authors:  G M Casey; B Morris; M Burnell; A Parberry; N Singh; A N Rosenthal
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

10.  Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing.

Authors:  Lindsay C Kobayashi; Jane Wardle; Christian von Wagner
Journal:  Prev Med       Date:  2013-11-25       Impact factor: 4.018

View more
  25 in total

1.  'Attorneys of the poor': Training physicians to tackle health inequalities.

Authors:  Michael Eb FitzPatrick; Charles Badu-Boateng; Christopher Huntley; Caitlin Morgan
Journal:  Future Healthc J       Date:  2021-03

Review 2.  Inequities in genetic testing for hereditary breast cancer: implications for public health practice.

Authors:  Ambreen Sayani
Journal:  J Community Genet       Date:  2018-05-20

3.  Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.

Authors:  Elizabeth S Burnside; Daniel Vulkan; Roger G Blanks; Stephen W Duffy
Journal:  Radiology       Date:  2018-04-03       Impact factor: 11.105

4.  Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.

Authors:  Prue C Allgood; Roberta Maroni; Sue Hudson; Judith Offman; Anne E Turnbull; Lesley Peacock; Jim Steel; Geraldine Kirby; Christine E Ingram; Julie Somers; Clare Fuller; Anthony G Threlfall; Rhian Gabe; Anthony J Maxwell; Julietta Patnick; Stephen W Duffy
Journal:  Lancet Oncol       Date:  2017-05-15       Impact factor: 41.316

5.  GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.

Authors:  Sally C Benton; Piers Butler; Katy Allen; Michelle Chesters; Sally Rickard; Sally Stanley; Richard Roope; Daniel Vulkan; Stephen W Duffy
Journal:  Br J Cancer       Date:  2017-05-18       Impact factor: 7.640

6.  Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women.

Authors:  Laura A V Marlow; Amanda J Chorley; Jessica Haddrell; Rebecca Ferrer; Jo Waller
Journal:  Eur J Cancer       Date:  2017-05-20       Impact factor: 9.162

7.  Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.

Authors:  Heling Bao; Lei Zhang; Limin Wang; Mei Zhang; Zhenping Zhao; Liwen Fang; Shu Cong; Maigeng Zhou; Linhong Wang
Journal:  Cancer Med       Date:  2018-03-24       Impact factor: 4.452

Review 8.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

9.  Recruitment to the "Breast-Activity and Healthy Eating After Diagnosis" (B-AHEAD) Randomized Controlled Trial.

Authors:  Mary Pegington; Judith E Adams; Nigel J Bundred; Anna M Campbell; Anthony Howell; Sacha J Howell; Shaun Speed; Jane Wolstenholme; Michelle N Harvie
Journal:  Integr Cancer Ther       Date:  2017-01-23       Impact factor: 3.279

Review 10.  Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis.

Authors:  Amanda J Chorley; Laura A V Marlow; Alice S Forster; Jessica B Haddrell; Jo Waller
Journal:  Psychooncology       Date:  2016-04-12       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.